DANIELLE LONG 12:15am August 26, 2024 New York University marketing professor, best-selling author and award-winning podcaster Scott Galloway Ozempicand similar GLP-1 medicationsfor diabetes and obesity are set to dramatically transform the market as the drug’s flow-on effects impact food, drinks, quick-service restaurant brands and beyond, New York University marketing professor, best-selling author and podcaster Scott Galloway says. Speaking in Sydney last week at the ADMA Global Forum, Mr Galloway predicted the GLP-1 agonists would have a more significant impact on the
Month: August 2024
original article (FT paywall) PDF Opinion Food diet Ultra-processed and fast food is everywhere — and causing us harm It’s time we saw these products for what they are, stripped of their disingenuous branding Simon Wroe The writer is the author of the novel ‘Chop Chop’ and of ‘Sweet Dreams’, an immersive cinema experience Picture a world where Tony the Tiger is caged, Ronald McDonald has hung up his clown shoes, and Colonel Sanders is court-martialled; where what’s euphemistically
:: Meeting Notes Ross Gittins’ dinner remarks Further insights into prevention: The largest leap in life expectancy occurred towards the end of the 1960s through to around 2010, where we enjoyed an unprecedented extra 20 years in life expectancy within that short period of time. Its thought this is mostly due prevention and subsequently improved treatment of cardiovascular disease (given that other determinants hadn’t changed that much during this time – prior to this period, nutrition and control communicable diseases).
Paul has offered three suggestions on what I could talk about tonight. First, an article in the Financial Times by Martin Wolf, about increased longevity, then a note on low productivity in hospitals and universities, and a third article about private health insurance and private hospitals on the Pearls and Irritations website by John Menadue. To these I could add another recent article on Pearls and Irritations by Steve Leeder, titled Keir Starmer may fix the NHS, but wholesale